This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering



Panntherapi is a biotech company developing Pannexin 1 channel blockers for the treatment of chronic neurological diseases, combining high efficacy and safety, using a unique platform based on human post operative brain tissues. In epilepsy, using ex vivo tissues from drug resistant patients and a rodent model of resistant epilepsy, blocking this activated target allows to drastically reduce the seizures (seizure free in >80% of samples and animals) with no impact on other basal activities.

We're bringing you

  • Startup spotlight pitch competition